Hook Anatomy of Hair Care
522 hair care ads, classified frame by frame. What a quarter of this category is really selling, and how rarely it says so out loud.
A quarter of this category sells a fix for hair loss. Almost none of it names the feeling.
Growth and anti-thinning treatment is the second-largest need this category sells against, just behind general styling. But once an ad is actually running, the emotional weight behind that purchase, the shame, the secrecy, the mirror-avoidance, almost never makes it into the script.
Hair loss is a quarter of what this category sells. It's rarely what the ad talks about.
Growth or anti-thinning treatment is named as the primary need behind 25% of ads in this sample, second only to general styling and maintenance at 27%. That's a real, sizeable share of the category built specifically around hair loss. What happens once the ad opens is a different story.
The euphemism does more work than the diagnosis. "Thinning or shedding" leads as a named concern in 15% of ads, which is almost forty times more often than "receding hairline or bald spot," a more specific and more visibly gendered way of describing the same thing, which shows up in 2 ads out of 522. The category will name the texture change. It won't name the condition.
That avoidance lines up with who the ads are actually built for. 83% explicitly target women and 17% stay unisex or ungendered. Within that second group, men are named specifically as the audience in only 3 ads total. Androgenic hair loss is common in men too, but the category's paid social presence barely acknowledges them as a buyer at all.
The one proven ingredient in the category is named twice.
What ships instead of an ingredient is a format. Multi-step systems and kits lead at 31%, serums, oils and leave-ins follow at 28%. The category sells a routine, not a compound, and it appears to have decided that naming a molecule (even a proven one) does less for conversion than showing a face and a result.
Skincare fights the needle out loud. Hair care doesn't fight anything.
Anti-aging skincare ads compare themselves to Botox or in-office treatments about 30% of the time. Hair care has an equally obvious foil sitting right there, transplants, PRP, wigs and extensions, and almost never reaches for it.
Every ad in this sample is also positioned as over-the-counter, with no prescription or telehealth gate signaled at the open. Whatever this category is competing against, it isn't fighting for it in the hook. It's simply not bringing up the comparison at all, consistent with the same instinct that keeps stigma and ingredients out of the script (01, 02).
The ad opens on a person four times out of five.
Every ad is classified by what holds the frame at 00:00, judged on the primary subject. 55% of ads open on a person speaking straight to camera, the single largest opening type in the sample. Add presenter-and-product opens and hairstylist or salon treatment shots, and a person is holding the frame at the open in 81% of the category. The product alone, with no person attached, opens just 7%.
That sequencing lines up with everything else in this report. The condition it barely names (01), the ingredient it never lists (02), and the transplant or PRP comparison it almost never makes (03) all sit further into the ad, once a face has already opened it. Hair care doesn't lead with the hard part. It leads with a person.
Two out of three ads offer nothing you could check.
Speed follows a pattern this audit keeps finding. 58% of ads state no timeframe. Among the 42% that do, "immediate or instant" leads at 24%, ahead of one to three months (13%), four or more months (2%), and every other window combined (3%). Hair growth is a months-long biological process. The most common promise in the category is that you won't have to wait.
The stylist fronts twice as many ads as the salon actually appears in.
Hair care has its own version of the dermatologist: the professional behind the chair. But the category films that authority the same way it films everyone else, at home, not at work.
A hairstylist or salon professional fronts 12% of ads, but a salon or barbershop actually shows up as the setting in only 6%. Bathrooms (29%) and bedrooms (23%) carry the category instead. The presenter is a woman 92% of the time, and one person alone is in frame in 89% of ads, the same solo, unstaged format this audit has now found to be common across the beauty and personal-care verticals it's looked at.
UGC and studio are two different grammars sharing one category.
The category splits between UGC selfie-style ads at 79% and studio-produced ads at 12%, with mixed cuts and podcast or salon interview clips making up the remainder. On paper that reads as a budget difference. In the data, it's closer to two different ways of making the same pitch.
| Measured on the same schema | UGC | Studio | Gap |
|---|---|---|---|
| Cast an everyday customer | 81% | 5% | +77pt |
| Cast a hairstylist or salon professional | 7% | 38% | -31pt |
| Filmed at an actual salon or barbershop | 3% | 19% | -16pt |
| Open with no concern stated, product-led | 55% | 70% | -16pt |
| Don't address hair-loss stigma at all | 88% | 92% | -4pt |
| Name no active ingredient | 96% | 97% | -1pt |
Who's on camera and where changes hard between the two formats: UGC leans almost entirely on an ordinary customer at home, studio leans on a hairstylist filmed somewhere that reads as a salon. But the avoidance this report keeps finding barely moves between them. Both formats skip the stigma at close to the same rate, and both are almost equally silent on naming an actual ingredient. Bigger production doesn't buy more candor, it just buys a different kind of authority to stand in front of the camera.
The category has agreed to talk around the exact thing that's driving the purchase.
Across 522 ads and 21 brands, the same avoidance shows up everywhere this audit looked. Skip the stigma, skip the ingredient, skip the comparison, promise speed instead of proof. None of it is a mistake - it's a formula the category has clearly settled into.
But it leaves the most human part of the purchase untouched. Almost nobody names the thing that actually gets someone to search for a hair-growth product at 11pm. The ad that says it plainly, without being clinical or clumsy about it, is working a lane this category has almost entirely left empty.
How this was measured.
The sample. 522 hair care video ads running in the United States, across 21 advertisers spanning styling, growth and anti-thinning, curl-specific, and damage-repair positioning. The roster is weighted toward the category's most active advertisers: Playa, Olaplex, and Prose alone account for 36% of the sample. Ads were sourced from the Meta Ads Library.
Classification. Each ad was processed with Recharm's AI tagging system against a schema purpose-built for haircare creative, covering the concern raised, stigma handling, ingredients, competitive framing, proof, and casting. Every ad carries the same field set, so any two ads are directly comparable on any dimension.
Reading the figures. Percentages are a share of all 522 ads unless stated otherwise, rounded to whole numbers. Shot-timing fields (when the product first appears, when the first claim is stated, first-cut timing) and operational metadata (annotator, ad ID, review flag) are excluded here as they don't add to the creative story this report is telling.
Stigma classification. An ad is counted as explicitly addressing stigma only when it names shame, secrecy, or embarrassment directly. Ads that offer general reassurance without naming any of those are classified as implied, not explicit.
Reuse. Every chart and figure on this page is free to reproduce with attribution to Recharm and a link to this page.